Putnam Investments »

Halozyme Therapeutics shares owned by Putnam Investments

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Putnam Investments from 13F filings

Historical chart of Putnam Investments investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Putnam Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Putnam Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $10M 272k 36.96
2023-09-30 $10M 267k 38.20
2023-06-30 $8.7M 240k 36.07
2023-03-31 $11M 286k 38.19
2022-12-31 $18M 310k 56.90
2022-09-30 $12M 310k 39.56
2022-06-30 $14M 313k 44.03
2022-03-31 $12M 311k 39.89
2021-12-31 $13M 320k 40.20
2021-09-30 $13M 310k 40.71
2021-06-30 $13M 286k 45.34
2021-03-31 $12M 286k 41.70
2020-12-31 $6.7M 158k 42.69
2017-03-31 $869k 66k 13.10
2016-12-31 $738k 75k 9.90
2016-09-30 $921k 77k 12.02
2016-06-30 $1.1M 127k 8.65
2016-03-31 $801k 85k 9.48
2015-12-31 $1.4M 83k 17.34
2015-09-30 $711k 53k 13.45